More On

FTC sues to stop Omnicare-PharMerica merger

Claims the deal would stifle competition and raise drug prices for seniors

The U.S. Federal Trade Commission (FTC) filed an administrative complaint on Friday, hoping to put the kibosh on Omnicare’s $441 million bid to buy its competitor PharMerica Corp.

According to the FTC, Omnicare and PharMerica are the top two long-term pharmacy service companies in the country, supplying drugs to nursing homes and long-term care facilities. Their joining would harm competition and potentially permit Omnicare to raise drug prices for senior citizens, the FTC says.

Join the Conversation

Advertisement. Closing in 15 seconds.